Some seven months after sounding the strategic search alarm, Avrobio will merge with Tectonic Therapeutic, with the latter’s GPCR-targeted meds now the combined company's clinical focus. The biotechs’ ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Tectonic Therapeutic, Inc. (“Tectonic”) (NASDAQ: TECX), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and ...
Tectonic Therapeutic, Inc.'s stock surged 120% after positive Phase 1b data for TX45 in treating PH-HFpEF, a condition with no approved therapies. TX45, an Fc-relaxin fusion protein, showed promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback